Lanier Biotherapeutics advances medical treatments to improve quality of living
We discover and develop antibody treatments to restore and improve better health: seeing, breathing, and believing!
A portfolio in focus
Seeing the bigger picture
Immuno-Oncology
Proprietary antibody offerings.
MT-6402 in the clinic with Molecular Templates.
Type 2 Inflammation
Moderate-to-severe conditions, like asthma, atopic dermatitis, chronic rhinosinusitis with nasal polyps, eosinophilic esophagitis and food allergies, with limited response to corticosteroid treatment.
A portfolio in focus
Seeing the bigger picture
Retinal
Biobetter multifunctional anti-VEGF antibodies.
Type 2 Inflammation
Moderate-to-severe conditions, like asthma, atopic dermatitis, chronic rhinosinusitis with nasal polyps, eosinophilic esophagitis and food allergies, with limited response to corticosteroid treatment.
Immuno-Oncology
Proprietary antibody offerings.
MT-6402 in the clinic with Molecular Templates.
Meet our team
Lanier Biotherapeutics is composed of some of the best minds in biotherapeutics. Visionaries with decades of experience and a dedication to advancing treatment for retinal, dermatological and respiratory diseases.
Daniel White
Chief Executive Officer & Director
Kirby Alton
Chairman
Martin Simonetti
Director
Christopher McLeod
Director
Investors
Lanier Biotherapeutics is funded by a group of visionary private investors
If you are interested in further exploring as an investor, please contact us.
Connect with us
Corporate Office
150 Ben Burton Rd,
Bogart, GA, 30622, USA
Bogart, GA, 30622, USA